• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Appropriate Dose Selection - How to Optimize Clinical Drug Development

Appropriate Dose Selection - How to Optimize Clinical Drug Development

Paperback

Series: Ernst Schering Foundation Symposium Proceedings, Book 59

Medical ReferenceChemistry

ISBN10: 3642421768
ISBN13: 9783642421761
Publisher: Springer Nature
Published: Nov 28 2014
Pages: 216
Weight: 0.62
Height: 0.51 Width: 5.50 Depth: 8.50
Language: English

Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers - based on the (known) pharmacology of the drug and/or biology of the underlying disease - along with exposure-response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.

Also in

Medical Reference